{"id":18670,"date":"2023-01-25T10:27:29","date_gmt":"2023-01-25T10:27:29","guid":{"rendered":"https:\/\/clinlabint.com\/?p=18670"},"modified":"2023-01-25T10:27:29","modified_gmt":"2023-01-25T10:27:29","slug":"fujifilm-enters-into-asset-purchase-agreement-to-acquire-inspiratas-digital-pathology-business","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/fujifilm-enters-into-asset-purchase-agreement-to-acquire-inspiratas-digital-pathology-business\/","title":{"rendered":"Fujifilm enters into asset purchase agreement to acquire Inspirata\u2019s digital pathology business"},"content":{"rendered":"
\n

\r\n\"Bio-Rad<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

Fujifilm enters into asset purchase agreement to acquire Inspirata\u2019s digital pathology business<\/h1>\/ in E-News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

FUJIFILM Corporation has entered into an asset purchase agreement to acquire the global digital pathology business Inspirata, based in Tampa, Florida. Upon completion of this agreement, Inspirata\u2019s Dynamyx digital pathology technology, employees and customers will become part of Fujifilm. The addition of digital pathology will expand Fujifilm\u2019s robust Synapse Enterprise Imaging offering to enable the integration of pathology images and data into a healthcare organization\u2019s electronic health record system and help to streamline care delivery for oncology patients and provider teams.<\/h3>\n

<\/p>\n

Building off the success of its established partnership with Inspirata, this acquisition marks Fujifilm\u2019s full-scale, global entry into the largely unpenetrated digital pathology market, where 85% of U.S., 86% of European, and 90% of Asian healthcare organizations are still running on analogue.<\/p>\n

\u201cAcquiring Inspirata\u2019s digital pathology business allows Fujifilm to be an even stronger healthcare partner \u2013 bridging a technological gap between pathology, radiology and oncology to facilitate a more collaborative approach to care delivery across the enterprise,\u201d says Teiichi Goto, president and CEO, representative director, FUJIFILM Corporation. \u201cWe\u2019re thrilled to welcome Inspirata\u2019s digital pathology experts to Fujifilm\u2019s growing medical informatics business, along with their renowned global customer base, as together we work to drive the digitization and advancement of healthcare.\u201d<\/p>\n

Dynamyx is an open, vendor-agnostic, end-to-end digital pathology solution. Dynamyx\u2019s software capabilities include using whole slide images from multiple scanning vendors to create an easier path for more pathology labs to digitize and realize the benefits of faster patient results, centralized imaging records, and enterprise access to images for all clinicians. It is installed in medical facilities that handle large volumes of pathological images across multiple lab locations, allowing the use of their preferred mix of laboratory and diagnostic technologies with confidence of full compatibility.<\/p>\n

It will become part of Fujifilm\u2019s Synapse Enter-prise Imaging portfolio \u2013 an award-winning suite of healthcare IT solutions that unify imaging, data access and workflows across the health system. \u201cSince launching our European partnership with Inspirata three years ago, we\u2019ve seen great success implementing our combined technologies in several healthcare organizations, notably in the UK,\u201d commented Masa Fukumoto, managing director, FUJIFILM Healthcare Europe and senior vice president FUJIFILM Medical Systems Europe.<\/p>\n

Digital pathology is the digitization of pathology slides to conduct software visualization analysis of a specimen rather than using microscopic slides. With a specialty as image and data heavy as pathology, digitization is key. Pathologists, clinicians, patients, researchers and biopharma companies alike may see benefits such as improved and more efficient workflows, enhanced collaboration, remote and centralized interpretation, faster patient results, overall cost savings, and increased precision of diagnosis.<\/p>\n<\/div><\/section>
\n

\"\"<\/div><\/div><\/div>
\n